Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01383174 · ClinicalTrials.gov registry record · NA

Nuevo Amanecer: Promoting the Psychosocial Health of Latinas

A NA study of Breast Neoplasms and Psychology, Social, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
151
Enrollment target
1
Study location

NCT01383174 is a NA study of Breast Neoplasms and Psychology, Social that has completed, run by University of California, San Francisco. The registered enrollment target is 151 participants, below the 567-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01383174, a NA study of Breast Neoplasms and Psychology, Social, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
151 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test whether a new program Nuevo Amanecer (A New Dawn), improves the quality of life of Latinas diagnosed with breast cancer. Trained Latina counselors who have had breast cancer provide support to recently diagnosed women. The investigators call these counselors peer support counselors.

Interventions

  • BEHAVIORAL Peer Support Program

Study Locations (1)

California

  • - Multiple Locations

Trial Details

FieldValue
Enrollment Target 151 participants
Start Date 2011-02
Est. Completion 2014-05
Phase NA

What the Registry Record Tells You About NCT01383174

The ClinicalTrials.gov registry entry for NCT01383174 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 567-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (73% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Peer Support Program is the first listed.

NCT01383174 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01383174 about?

NCT01383174 is a clinical study titled "Nuevo Amanecer: Promoting the Psychosocial Health of Latinas". The purpose of this study is to test whether a new program Nuevo Amanecer (A New Dawn), improves the quality of life of Latinas diagnosed with breast cancer. Trained Latina counselors who have had breast cancer provide support to recently diagnosed women. The investigators call these counselors peer...

What is the current status of trial NCT01383174?

This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2011-02. Estimated completion is 2014-05.

What conditions does trial NCT01383174 study?

This clinical trial studies the following conditions: Breast Neoplasms, Psychology, Social.

What interventions are being tested in trial NCT01383174?

The interventions under investigation include: Peer Support Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT01383174?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01383174 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.